Clinical Trials
3
Active:0
Completed:1
Trial Phases
2 Phases
Phase 1:2
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (66.7%)Phase 2
1 (33.3%)MTG201 Plus Nivolumab in Patients With Relapsed Pleural Mesothelioma
Phase 2
- Conditions
- Malignant Pleural Mesothelioma
- Interventions
- First Posted Date
- 2019-07-09
- Last Posted Date
- 2022-06-16
- Lead Sponsor
- Momotaro-Gene Inc.
- Target Recruit Count
- 12
- Registration Number
- NCT04013334
- Locations
- 🇺🇸
Baylor College of Medicine, Houston, Texas, United States
Use of Recombinant Adenovirus Therapy to Treat Localized Prostate Cancer
- First Posted Date
- 2013-08-29
- Last Posted Date
- 2020-09-04
- Lead Sponsor
- Momotaro-Gene Inc.
- Target Recruit Count
- 28
- Registration Number
- NCT01931046
- Locations
- 🇺🇸
UCSD Moores Cancer Center, San Diego, California, United States
🇺🇸Brigham and Women's Hospital, Boston, Massachusetts, United States
🇺🇸The Methodist Hospital Research Institute, Houston, Texas, United States
Neoadjuvant Study of In-situ REIC/Dkk-3 in Prostate Cancer
Phase 1
Withdrawn
- Conditions
- Prostate Cancer
- First Posted Date
- 2010-09-09
- Last Posted Date
- 2013-08-23
- Lead Sponsor
- Momotaro-Gene Inc.
- Registration Number
- NCT01197209
- Locations
- 🇺🇸
Mount Sinai School of Medicine, New York, New York, United States
News
No news found